Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Genome-wide Association Study of Pituitary Tumors

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2011 by Huashan Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Zhaoyun Zhang, Huashan Hospital
ClinicalTrials.gov Identifier:
NCT01442220
First received: September 26, 2011
Last updated: September 27, 2011
Last verified: September 2011
  Purpose

Pituitary adenomas is a very common disease, but the cause and genetics hasn't been identified. The investigators are going to use genome-wide association study to identify genes that may be related to pituitary adenomas.


Condition
Pituitary Adenomas

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Genome-wide Association Study of Pituitary Tumors

Resource links provided by NLM:


Further study details as provided by Huashan Hospital:

Biospecimen Retention:   Samples With DNA

DNA samples


Estimated Enrollment: 12500
Study Start Date: September 2011
Estimated Study Completion Date: July 2014
Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Patients diagnosed with pituitary adenomas and healthy controls will be included.

Criteria

Inclusion Criteria:

  • patients diagnosed with pituitary adenomas

Exclusion Criteria:

  • patients with a family history of endocrine tumors
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01442220

Contacts
Contact: Yao Zhang, Dr. 86-13916872553 zhaoyaohs@vip.sina.com

Locations
China, Shanghai
Huashan Hospital Recruiting
Shanghai, Shanghai, China, 200040
Contact: Yao Zhao    86-13916872553    zhaoyaohs@vip.sina.com   
Principal Investigator: Yao Zhao         
Sponsors and Collaborators
Huashan Hospital
Investigators
Principal Investigator: Yao Zhao, M.D. Huashan Hospital
  More Information

No publications provided

Responsible Party: Zhaoyun Zhang, Doctor, Huashan Hospital
ClinicalTrials.gov Identifier: NCT01442220     History of Changes
Other Study ID Numbers: KY2011-277
Study First Received: September 26, 2011
Last Updated: September 27, 2011
Health Authority: China: Food and Drug Administration

Additional relevant MeSH terms:
Pituitary Neoplasms
Brain Diseases
Brain Neoplasms
Central Nervous System Diseases
Central Nervous System Neoplasms
Endocrine Gland Neoplasms
Endocrine System Diseases
Hypothalamic Diseases
Hypothalamic Neoplasms
Neoplasms
Neoplasms by Site
Nervous System Diseases
Nervous System Neoplasms
Pituitary Diseases
Supratentorial Neoplasms

ClinicalTrials.gov processed this record on November 25, 2014